Stock comparison
ELI LILLY & Co is 253.4x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($1.146 T vs $4.52 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
LLY is larger
ELI LILLY & Co is 253.4x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($1.146 T vs $4.52 B).
Market value leader
LLY
ELI LILLY & Co is 253.4x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($1.146 T vs $4.52 B).
Revenue leader
LLY
ACAD: $1.07B vs LLY: $65.18B.
Profit leader
LLY
ACAD: $391.00M vs LLY: $20.64B.
Margin leader
ACAD
ACAD: 36.5% vs LLY: 31.7% net margin.
| Metric | ACAD | LLY |
|---|---|---|
| Market cap | $4.52 B | $1.146 T |
| US-listed rank | #1497 | #10 |
| Revenue (latest FY) | $1.07B | $65.18B |
| Net income (latest FY) | $391.00M | $20.64B |
| Net margin | 36.5% | 31.7% |
| P/E (trailing FY) | 11.6x | 55.5x |
| SEC filings | 1,357 | 995 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ELI LILLY & Co is 253.4x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($1.146 T vs $4.52 B).
In their latest fiscal years, ACADIA PHARMACEUTICALS INC reported $1.07B in revenue while ELI LILLY & Co reported $65.18B.
Full pages: ACADIA PHARMACEUTICALS INC and ELI LILLY & Co, or browse the full rankings.